Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining...

por Fredly, Hanne, Gjertsen, Bjørn Tore, Bruserud, Øystein
Publicado em 2013

Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia

por Sletta, Kristine Yttersian, Castells, Oriol, Gjertsen, Bjørn Tore
Publicado no Front Oncol (2021)

Intensive chemotherapy for acute myeloid leukemia differentially affects circulating T(C)1, T(H)1, T(H)17 and T(REG )cells

por Ersvaer, Elisabeth, Liseth, Knut, Skavland, Jørn, Gjertsen, Bjørn Tore, Bruserud, Øystein
Publicado em 2010

Targeted Therapy of FLT3 in Treatment of AML—Current Status and Future Directions

por Engen, Caroline Benedicte Nitter, Wergeland, Line, Skavland, Jørn, Gjertsen, Bjørn Tore
Publicado no J Clin Med (2014)

Functional p53 is required for rapid restoration of daunorubicin-induced lesions of the spleen

por Herfindal, Lars, Myhren, Lene, Gjertsen, Bjørn Tore, Døskeland, Stein Ove, Gausdal, Gro
Publicado em 2013

Single Cell Detection of the p53 Protein by Mass Cytometry

por Fagerholt, Oda Helen Eck, Hellesøy, Monica, Gullaksen, Stein-Erik, Gjertsen, Bjørn Tore
Publicado no Cancers (Basel) (2020)

Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation

por Hemsing, Anette Lodvir, Gjertsen, Bjørn Tore, Spetalen, Signe, Helgeland, Lars, Reikvam, Håkon
Publicado no SAGE Open Med Case Rep (2021)

Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells

por Wergeland, Line, Sjøholt, Gry, Haaland, Ingvild, Hovland, Randi, Bruserud, Øystein, Gjertsen, Bjørn Tore
Publicado em 2007

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia

por Fredly, Hanne, Ersvær, Elisabeth, Kittang, Astrid Olsnes, Tsykunova, Galina, Gjertsen, Bjørn Tore, Bruserud, Øystein
Publicado em 2013

4-Alkylated Silver–N-Heterocyclic Carbene (NHC) Complexes with Cytotoxic Effects in Leukemia Cells

por Sandtorv, Alexander H, Leitch, Calum, Bedringaas, Siv Lise, Gjertsen, Bjørn Tore, Bjørsvik, Hans-René
Publicado no ChemMedChem (2015)

The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer

por Helland, Øystein, Popa, Mihaela, Bischof, Katharina, Gjertsen, Bjørn Tore, McCormack, Emmet, Bjørge, Line
Publicado no PLoS One (2016)

Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chem...

por Grønningsæter, Ida Sofie, Fredly, Hanne Kristin, Gjertsen, Bjørn Tore, Hatfield, Kimberley Joanne, Bruserud, Øystein
Publicado no Cells (2019)

Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables

por Van Belle, Werner, Ånensen, Nina, Haaland, Ingvild, Bruserud, Øystein, Høgda, Kjell-Arild, Gjertsen, Bjørn Tore
Publicado em 2006

Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling

por Mercatelli, Daniele, Bortolotti, Massimo, Andresen, Vibeke, Sulen, André, Polito, Letizia, Gjertsen, Bjørn Tore, Bolognesi, Andrea
Publicado no Front Pharmacol (2020)

Interactions of the Natural Product (+)-Avrainvillamide with Nucleophosmin and Exportin-1 Mediate the Cellular Localization of Nucleophosmin and its AML-Associated Mutants

por Mukherjee, Herschel, Chan, Kok-Ping, Andresen, Vibeke, Hanley, Mariah L., Gjertsen, Bjørn Tore, Myers, Andrew G.
Publicado no ACS Chem Biol (2015)

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatme...

por Reikvam, Håkon, Hovland, Randi, Forthun, Rakel Brendsdal, Erdal, Sigrid, Gjertsen, Bjørn Tore, Fredly, Hanne, Bruserud, Øystein
Publicado no BMC Cancer (2017)

The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity

por Ersvaer, Elisabeth, Kittang, Astrid Olsnes, Hampson, Peter, Sand, Kristoffer, Gjertsen, Bjørn Tore, Lord, Janet M., Bruserud, Øystein
Publicado em 2010

Gel2DE - A software tool for correlation analysis of 2D gel electrophoresis data

por Øye, Ola Kristoffer, Jørgensen, Katarina M, Hjelle, Sigrun M, Sulen, André, Ulvang, Dag Magne, Gjertsen, Bjørn Tore
Publicado em 2013

First In-Mouse Development and Application of a Surgically Relevant Xenograft Model of Ovarian Carcinoma

por Helland, Øystein, Popa, Mihaela, Vintermyr, Olav K., Molven, Anders, Gjertsen, Bjørn Tore, Bjørge, Line, McCormack, Emmet
Publicado em 2014

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation

por Reikvam, Håkon, Skavland, Jørn, Gullaksen, Stein-Erik, Hovland, Randi, Gedde-Dahl, Tobias, Bruserud, Øystein, Gjertsen, Bjørn Tore
Publicado no Case Rep Hematol (2018)